Navigation Links
Study pinpoints novel cancer gene and biomarker
Date:6/24/2009

BOSTON--Dana-Farber Cancer Institute scientists' discovery of a cancer-causing gene the first in its family to be linked to cancer demonstrates how the panoramic view of genomics and the close-up perspective of molecular biology are needed to determine which genes are involved in cancer and which are mere bystanders. The findings are reported in the June 25 issue of the journal Nature.

"In the coming years, we can expect genomic studies [which chart the activity of thousands of cell genes] to generate hundreds or thousands of genetic elements of interest in cancer research," says the study's senior author, Lynda Chin, MD, of Dana-Farber. "To narrow that group to the genes that actually drive cancer growth and metastasis, it's necessary to do functional studies, which focus on what individual genes do to turn a cell cancerous, and mechanistic studies, which examine how they turn cells cancerous and in what setting. It is a long and intensive effort that will leverage knowledge from different fields and different model systems."

In the study, Chin, lead author Kenneth Scott, PhD, of Dana-Farber, and their colleagues worked their way through a series of experiments -- in yeast cells, multiple types of human cancer cells, laboratory cell cultures, and mouse models - to demonstrate that a surplus of a gene known as GOLPH3 can spur cancer cell growth in a variety of tissues. It is the first gene associated with the Golgi complex, a tiny packaging plant that prepares proteins for their journey within and outside the cell, which has been found to play a role in cancer. Chin's team also found that the protein made from GOLPH3 may serve as a biomarker for tumors that can be effectively treated with the chemotherapy drug rapamycin: tumors with a high level of the protein are more apt to shrink in response to the drug than those with low levels.

The study began with an observation made years ago that a section of chromosome 5p13 is oft
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...MyCareTeam, Inc., a leading vendor of Internet-bas...ed the newest version of its software offering. T...ve heart failure and weight management capabilitie...features. , Acton, MA. ...ading vendor of Internet-based chronic disease man...
(Date:12/2/2009)... Dec. 2 US Farms, Inc. (...ing, Nursery and Wellness products, is pleased to ...ducts at the Cook,sware A,faire in Oakland, Calif...., For additional information, contact US Farms, In...visit http://cookswareafaire.com ,, Victor Br...
(Date:12/2/2009)...y for Thursday, Dec. 3 ,, Head of Army,s Warr...g of Army Wounded Warriors; Army Embraces Reality ...WASHINGTON, Dec. 2 The ...ization on Disability: ,, WHAT: Wounded veter...rrior (AW2) program,s National Organization on Dis...
(Date:12/2/2009)...UE, Wash., Dec. 2 drugst...etailer of health, beauty, vision and pharmacy pro...tomers in China, India, and Brazil, plus 50 additi...ternational customers can shop for non-prescriptio...international.drugstore.com with pricing in their...
(Date:12/2/2009)...to death from TB, not Addison,s, researcher says ...- The woman behind Pride and Prejudice and Emm...on,s disease, as has long been believed, says one ... 1817 at the age of 41, many historians and other ...ase, which affects the adrenal glands and creates ...
Breaking Medicine News(10 mins):Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:US Farms, Inc. Showcasing Aloe365(TM) Product Line at Cook'sware A'faire at Oakland Zoo 2Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers 2Health News:New Light on Jane Austen's Final Chapter 2
... Ike will Receive Benefits of, Member Emergency A...ss., DALLAS, Sept. 11 As predictions increase fo...when it reaches the Texas Gulf Coast,Blue Cross an...escription medications can be,critical for members...
...,CYBX) today announced that Dan Moore, President a...President, Finance and Chief Financial,Officer, wi...nce in New,York on Wednesday, September 24, 2008 a...st a webcast of the presentation,live and by repla...
...em than obesity itself, study says , , TH...he top "health" concern among parents with overwei... , Parents of these children, aged 6 to 13, also ...by the University of Michigan C.S. Mott Children,s...
...,(Amex: HH ) today announced that Richard Whitbec...,s Portamedic division, the largest paramedical,ex...ng health information,to reduce underwriting risk,...ck has held senior executive positions in the insu...
...ar,types of health care coverage are projected to ...er of 2008 and into 2009, according to a national,... among the results of a survey released today by B...th,insurers, HMOs and third-party administrators.,...
... Texas, Sept. 11 Over 90 percent of newly minted,... during their training,and 80 percent received two...urvey conducted by Merritt, Hawkins & Associates, ...ntense,recruiting efforts," notes Mark Smith, pres...
Other Medicine News:Health News:Preparations by Blue Cross and Blue Shield of Texas Will Assist Members Affected by Hurricane Ike 2Health News:Cyberonics to Present at UBS Global Life Sciences Conference 2Health News:Bullying Top Concern of Parents With Overweight Child 2Health News:Hooper Holmes Names Richard Whitbeck President of Portamedic Division 2Health News:Hooper Holmes Names Richard Whitbeck President of Portamedic Division 3Health News:Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey 2Health News:Health Care Cost Increases to Continue at Double Digit Rates, According to Buck Consultants Survey 3Health News:Survey: New Doctors Receive Dozens of Job Solicitations 2
(Date:12/2/2009)... PHILADELPHIA, Pennsylvania, December 2 /PRNews...HPGY ), the global specialty biopharmaceutical,com... with Teva,Pharmaceuticals USA, Inc. ("Teva") over...ersion of ADDERALL XR. Shire has been supplying Te... 1, 2009. Shire,s ability to supply,the product ha...
(Date:12/2/2009)...OCKVILLE, Md., Dec. 2 No...ble initial results from the first stage of a two-... and immunogenicity of the company,s 2009 H1N1 vir... Novavax is conducting this study in collaboratio...gistration of the vaccine in Mexico and potentiall...
(Date:12/2/2009)...CLINE VILLAGE, Nev., Dec. 2 /PRNewswire-FirstCall/...ay announced that it has established the per share...pecial dividend as $1.67 per share. The dividend w... the Company,s stock as of the December 1, 2009 re...roximate per share amount of the dividend at $1.67...
Breaking Medicine Technology:Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 1Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 2Knome Launches First Platform Agnostic Human Genome Sequencing and Analysis Service for Researchers 14898 3Benevolence Beyond Politics Inc Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide 6372 1Benevolence Beyond Politics Inc Announces Position to Provide Financial and Logistical Support for Humanitarian and Medical Missions Worldwide 6372 2Sinovac Files Shelf Registration Statement 6367 1Sinovac Files Shelf Registration Statement 6367 2Sinovac Files Shelf Registration Statement 6367 3
Basic Fragment Set
...e benefits of TiMAX™ material have been appl...rge Fragment plates and screws offer greater stren...ng compatibility over traditional titanium and sta...n the TiMAX bone screws provides greater resistanc...
Pelvic Fragment Set
Foot Fragment Set
Medicine Products: